SEI Investments’s Nurix Therapeutics NRIX Stock Holding History

SEI Investments’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Buy	82,108 +46,132	+128%	+$765K	﹤0.01%	2232
2025 Q4	$682K	Buy	+35,976	New	+$517K	﹤0.01%	2365
2025 Q3	–	Sell	-13,833	Closed	-$158K	–	2881
2025 Q2	$158K	Hold	13,833	–	–	﹤0.01%	2615
2025 Q1	$164K	Buy	+13,833	New	+$231K	﹤0.01%	2504

Other funds holding NRIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

SEI Investments's NRIX Position: Q1 2026 in Review

SEI Investments increased its Nurix Therapeutics (NRIX) stake by 128% in Q1 2026, buying an estimated $765K and bringing the position to 82,108 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

SEI Investments first reported a position in NRIX in Q1 2025 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

SEI Investments held 82,108 shares of Nurix Therapeutics worth $1.27M as of Q1 2026.
SEI Investments bought 46,132 Nurix Therapeutics shares in Q1 2026, an estimated $765K.
Nurix Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2232 holding.
SEI Investments first reported a position in Nurix Therapeutics in Q1 2025 and has held it in 4 quarters since.
195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.